Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host

Circulating Precursor CCR7loPD-1hi CXCR5+ CD4+ T Cells Indicate Tfh Cell Activity and Promote Antibody Responses upon Antigen Reexposure

(2013) Jing He et al.   IMMUNITY

Slow increase in IgG avidity correlates with prevention of human cytomegalovirus transmission to the fetus

(2013) Milena Furione et al.   JOURNAL OF MEDICAL VIROLOGY

Comparative Analysis of gO Isoforms Reveals that Strains of Human Cytomegalovirus Differ in the Ratio of gH/gL/gO and gH/gL/UL128-131 in the Virion Envelope

(2013) M. Zhou et al.   JOURNAL OF VIROLOGY

Fetal Human Cytomegalovirus Transmission Correlates with Delayed Maternal Antibodies to gH/gL/pUL128-130-131 Complex during Primary Infection

(2013) Daniele Lilleri et al.   PLoS One

Antibodies Against Neutralization Epitopes of Human Cytomegalovirus gH/gL/pUL128-130-131 Complex and Virus Spreading May Correlate with Virus Control In Vivo

(2012) Daniele Lilleri et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Kinetics of human cytomegalovirus (HCMV) DNAemia in transplanted patients expressed in international units as determined with the Abbott RealTime CMV assay and an in-house assay

(2012) Milena Furione et al.   JOURNAL OF CLINICAL VIROLOGY

Antibodies against the gH/gL/UL128/UL130/UL131 Complex Comprise the Majority of the Anti-Cytomegalovirus (Anti-CMV) Neutralizing Antibody Response in CMV Hyperimmune Globulin

(2012) A. E. Fouts et al.   JOURNAL OF VIROLOGY

Serum antibody response to the gH/gL/pUL128–131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections

(2011) Emilia Genini et al.   JOURNAL OF CLINICAL VIROLOGY

Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: A 20-year experience

(2011) Maria Grazia Revello et al.   JOURNAL OF CLINICAL VIROLOGY

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

(2011) Paul D Griffiths et al.   LANCET

B Cell Repertoire Analysis Identifies New Antigenic Domains on Glycoprotein B of Human Cytomegalovirus which Are Target of Neutralizing Antibodies

(2011) Sonja Pötzsch et al.   PLoS Pathogens

Comparative evaluation of eight commercial human cytomegalovirus IgG avidity assays

(2010) Maria Grazia Revello et al.   JOURNAL OF CLINICAL VIROLOGY

Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications

(2010) M. Grazia Revello et al.   REVIEWS IN MEDICAL VIROLOGY

Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host

(2009) Daniele Lilleri et al.   CLINICAL IMMUNOLOGY

Isolation of Human Monoclonal Antibodies That Potently Neutralize Human Cytomegalovirus Infection by Targeting Different Epitopes on the gH/gL/UL128-131A Complex

(2009) A. Macagno et al.   JOURNAL OF VIROLOGY

Vaccine Prevention of Maternal Cytomegalovirus Infection

(2009) Robert F. Pass et al.   NEW ENGLAND JOURNAL OF MEDICINE

Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection

(2008) G. Gerna et al.   JOURNAL OF GENERAL VIROLOGY

Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection

(2008) Xiaohong Cui et al.   VACCINE